Subscribe

Digital Therapeutics Today - October 6, 2026

Daily digital therapeutics roundup: 3 stories curated October 6, 2026. Lead: FDA Clearance Positions Click Therapeutics’ Motivista for Commercial Rollout.

Digital Therapeutics Today - October 6, 2026

The latest in digital therapeutics: 3 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: FDA Clearance Positions Click Therapeutics’ Motivista for Commercial Rollout.

FDA Clearance Positions Click Therapeutics’ Motivista for Commercial Rollout

TipRanks2026-10-06

FDA Clears Motivista (CT-155), the First Authorized Treatment for Negative Schizophrenia Symptoms

The Manila Times2026-10-05

Meet Motivista: Click Therapeutics debuts first-of-its-kind schizophrenia digital therapeutic

Fierce Biotech2026-10-05

Follow the full firehose on the HTC Wire, refreshed automatically every day.

Reach the people behind these stories. HealthTech Cube demand gen programs deliver qualified healthcare technology leads from $49.50 per lead - see packages or download the 2026 media kit.